Alacot
Generic Name
Olopatadine Hydrochloride Ophthalmic Solution 0.1%
Manufacturer
Apex Pharma Ltd.
Country
Bangladesh
Loading images...
Price Details
Current market pricing information
| Variant | Unit Price | Strip Price |
|---|---|---|
| alacot 01 eye drop | ৳ 110.34 | N/A |
Description
Overview of the medicine
Alacot 0.1% Eye Drop contains Olopatadine, an ophthalmic antihistamine and mast cell stabilizer, used to relieve ocular itching and redness associated with allergic conjunctivitis.
Uses & Indications
Dosage
Adults
One drop in each affected eye twice a day (approximately 6 to 8 hours apart).
Elderly
No specific dosage adjustment is required for elderly patients.
Renal_impairment
No dosage adjustment is necessary due to minimal systemic absorption.
How to Take
For topical ophthalmic use only. Tilt head back, pull down the lower eyelid to form a pouch, and instill one drop into the conjunctival sac. Close eye gently. Avoid touching the dropper tip to the eye or any other surface.
Mechanism of Action
Olopatadine acts as a selective H1-receptor antagonist, blocking histamine's effects. It also inhibits the release of histamine from mast cells, thereby reducing allergic symptoms like itching and redness in the eyes.
Pharmacokinetics
Onset
Onset of action within 30 minutes.
Excretion
Primarily renal excretion of unchanged drug.
Half life
Systemic half-life approximately 3 hours.
Absorption
Minimal systemic absorption after topical ocular administration.
Metabolism
Minimal hepatic metabolism due to low systemic absorption.
Side Effects
Contraindications
- Known hypersensitivity to olopatadine hydrochloride or any component of the formulation.
Drug Interactions
Other Ophthalmic Preparations
If more than one topical ophthalmic drug is being used, they should be administered at least 5 minutes apart.
Storage
Store at room temperature (below 30°C). Protect from light. Do not freeze. Keep out of reach of children.
Overdose
Overdose is unlikely with topical ocular administration. If accidental ingestion occurs, seek medical advice.
Pregnancy & Lactation
Pregnancy Category B. Use in pregnant or lactating women only if clearly needed and the potential benefits outweigh the potential risks to the fetus or infant. Consult a doctor.
Frequently Asked Questions
Common questions about this medicine
Pack Sizes
Shelf Life
Typically 2-3 years unopened; 28 days after opening.
Availability
Available in pharmacies
Approval Status
FDA Approved, DGDA Approved
Patent Status
Off-patent
Clinical Trials
Extensive clinical trials have demonstrated the efficacy and safety of olopatadine for allergic conjunctivitis.
Lab Monitoring
- Not routinely required due to minimal systemic exposure.
Doctor Notes
- Emphasize proper administration technique to patients to minimize contamination.
- Advise patients not to wear contact lenses if eyes are irritated or red and to wait 10 minutes after instillation before reinserting contact lenses.
Patient Guidelines
- Do not touch the dropper tip to the eye or any other surface to avoid contamination.
- Do not wear contact lenses if your eyes are red. Wait at least 10 minutes after instilling the drop before reinserting contact lenses.
- Discard the bottle 28 days after opening.
Missed Dose Advice
If a dose is missed, apply it as soon as you remember. If it is almost time for the next dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose.
Driving Precautions
May cause temporary blurred vision. Patients should be advised to wait until their vision clears before driving or operating machinery.
Lifestyle Advice
- Avoid known allergens that trigger allergic conjunctivitis.
- Maintain good eye hygiene.
Alternative Medicines in Bangladesh
Similar medicines available in the market
Global Brand Names
International brand names for this medicine. Click a brand to search for detailed information.